Spots Global Cancer Trial Database for vitamin b12
Every month we try and update this database with for vitamin b12 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies | NCT02106650 | Relapsed Periph... Refractory Peri... | Folotyn and Leu... Folic Acid Vitamin B12 | 18 Years - | Acrotech Biopharma Inc. | |
| Phase 2 Trial of Bevacizumab in Combination With Pemetrexed | NCT00227019 | Non-small Cell ... Lung Cancer Neoplasm Metast... | Bevacizumab Pemetrexed Vitamin B12 Folate Dexamethasone | 18 Years - | Stanford University | |
| Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | NCT00364923 | Peripheral T-ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
| Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | NCT00722553 | Carcinoma, Tran... Bladder Cancer Bladder Neoplas... | Pralatrexate In... Vitamin B12 Folic Acid | 18 Years - | Acrotech Biopharma Inc. | |
| Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery | NCT00541073 | Malignant Mesot... | vitamin B12 cisplatin pemetrexed diso... gene expression... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | NCT00364923 | Peripheral T-ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
| A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | NCT00609518 | Non Small Cell ... | pemetrexed Folic acid Folic Acid Vitamin B12 dexamethasone dexamethasone | 18 Years - | Eli Lilly and Company | |
| NORVIT and WENBIT - Long-term Follow-up | NCT00671346 | Cancer Myocardial Infa... Cerebrovascular... | 27 Years - 86 Years | Haukeland University Hospital | ||
| Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer | NCT00216099 | Prostate Cancer | Pemetrexed Folic Acid Vitamin B12 | 18 Years - | Hoosier Cancer Research Network | |
| Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) | NCT01183065 | Head and Neck C... | Pralatrexate Wi... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer | NCT00402883 | Lung Cancer | Bevacizumab Pemetrexed Radiotherapy Folic Acid vitamin B12 carboplatin | 18 Years - | SCRI Development Innovations, LLC | |
| Epigallocatechin Gallate and Other Antural Compounds in HPV Infections | NCT06098456 | Papilloma-induc... | EGCG, FA, HA, B... | 20 Years - 45 Years | Centro di Ricerca Clinica Salentino | |
| Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy | NCT02795572 | Peripheral Neur... | Vitamin D Vitamin B6 Vitamin B12 Omega-3 Fatty A... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer | NCT01057589 | Head and Neck N... | Pemetrexed Cetuximab Cisplatin Folic Acid Vitamin B12 | 18 Years - | Eli Lilly and Company | |
| Vitamin B12 for Aromatase Inhibitors Musculoskeletal Symptoms | NCT03069313 | Relief of Joint... | Vitamin B12 | 18 Years - | Texas Tech University Health Sciences Center, El Paso | |
| Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy | NCT02795572 | Peripheral Neur... | Vitamin D Vitamin B6 Vitamin B12 Omega-3 Fatty A... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer | NCT03101579 | Leptomeningeal ... | Pemetrexed Dexamethasone Folic Acid Vitamin B12 | 18 Years - 75 Years | The First Hospital of Jilin University | |
| Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer | NCT00216099 | Prostate Cancer | Pemetrexed Folic Acid Vitamin B12 | 18 Years - | Hoosier Cancer Research Network | |
| NORVIT and WENBIT - Long-term Follow-up | NCT00671346 | Cancer Myocardial Infa... Cerebrovascular... | 27 Years - 86 Years | Haukeland University Hospital | ||
| Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy | NCT02795572 | Peripheral Neur... | Vitamin D Vitamin B6 Vitamin B12 Omega-3 Fatty A... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | NCT02013362 | Peripheral T-ce... | Pralatrexate in... Vitamin B12 Folic Acid | 20 Years - | Mundipharma K.K. | |
| Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) | NCT01183065 | Head and Neck C... | Pralatrexate Wi... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | NCT00364923 | Peripheral T-ce... | Pralatrexate In... | 18 Years - | Acrotech Biopharma Inc. | |
| Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | NCT00722553 | Carcinoma, Tran... Bladder Cancer Bladder Neoplas... | Pralatrexate In... Vitamin B12 Folic Acid | 18 Years - | Acrotech Biopharma Inc. | |
| Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | NCT00998946 | Lymphoma, B-Cel... | Pralatrexate Vitamin B12 Folic Acid | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer | NCT01057589 | Head and Neck N... | Pemetrexed Cetuximab Cisplatin Folic Acid Vitamin B12 | 18 Years - | Eli Lilly and Company | |
| NORVIT and WENBIT - Long-term Follow-up | NCT00671346 | Cancer Myocardial Infa... Cerebrovascular... | 27 Years - 86 Years | Haukeland University Hospital | ||
| Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies | NCT02106650 | Relapsed Periph... Refractory Peri... | Folotyn and Leu... Folic Acid Vitamin B12 | 18 Years - | Acrotech Biopharma Inc. | |
| A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer | NCT01165021 | Non Small Cell ... | Pemetrexed Cisplatin Folic Acid Vitamin B12 Dexamethasone | 18 Years - | Eli Lilly and Company | |
| Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer | NCT03101579 | Leptomeningeal ... | Pemetrexed Dexamethasone Folic Acid Vitamin B12 | 18 Years - 75 Years | The First Hospital of Jilin University | |
| A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | NCT00609518 | Non Small Cell ... | pemetrexed Folic acid Folic Acid Vitamin B12 dexamethasone dexamethasone | 18 Years - | Eli Lilly and Company | |
| Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer | NCT00402883 | Lung Cancer | Bevacizumab Pemetrexed Radiotherapy Folic Acid vitamin B12 carboplatin | 18 Years - | SCRI Development Innovations, LLC | |
| Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma | NCT00554827 | Cutaneous T-cel... | Vitamin B12 Folic Acid Pralatrexate | 18 Years - | Acrotech Biopharma Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
